[1] Govindan R,Page N,Morgensztern D,et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance,epidemiologic,and end results database. J Clin Oncol,2006,24:4539-4544. [2] Parkin DM,Bray F,Ferlay J,et al. Global cancer statistics,2002. CA Cancer J Clin,2005,55:74-108. [3] Baymana NA,Sheikha H,Kularatneb B,et al. Radiotherapy for small-cell lung cancer-Where are we heading? Lung Cancer,2009,63:307-314. [4] Faivre-Finn C,Lorigan P,West C,et al. Thoracic radiation therapy for limited-stage small-cell lung cancer: unanswered questions. Clin Lung Cancer,2005,7:23-29. [5] Pignon JP,Arriagada R,Ihde DC,et al. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med,1992,327:1618-1624. [6] Socinski MA,Bogart JA. Limited-stage small-cell lung cancer: the current status of combined-modality therapy. J Clin Oncol,2007,25:4137-4145. [7] Takada M,Fukuoka M,Kawahara M,et al. Phase Ⅲ study of concurrent vs sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan clinical oncology group study 9104. J Clin Oncol,2002,20:3054-3060. [8] 乔田奎,周道安,辛立,等.卡铂与足叶乙甙联合放射同步治疗局限期小细胞肺癌的临床疗效观察.中华结核和呼吸杂志,2004,27:237-239. [9] Wheatley-Price P,Ma C, Ashcroft LF,et al. The strength of female sex as a prognostic factor in small-cell lung cancer: a pooled analysis of chemotherapy trials from the Manchester lung group and medical research council clinical trials unit. Ann Oncol,2010,21:232-237. [10] Paesmans M,Sculier JP,Lecomte J,et al. Prognostic factors for patients with small cell lung carcinoma:analysis of a series of 763 patients included in 4 consecutive prospective trials with a minimum follow-up of 5 years. Cancer,2000,89:523-533. [11] Chen J,Jiang RX,Garces YI,et al. Prognostic factors for limited-stage small cell lung cancer: a study of 284 patients. Lung Cancer,2010,67:221-226. [12] 朱慧,王燕,周宗玫,等.154例广泛期小细胞肺癌治疗结果预后因素分析.中华放射肿瘤学杂志,2011,20:96-99.
2012, Vol. 21 
